… mendations for first-line and second-line antiviral agents. … Drug Administration for treatment
of chronic hepatitis B based on … for hepatitis B e antigen (HBeAg), 48 weeks of treatment with …

Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are potent nucleos(t)ide analogues (NUCs)
recommended as first‐line monotherapies for chronic hepatitis B. In Phase III trials, …

… As treatments for naive patients with hepatitis C fall in … treatments for naive patients. Each
direct comparison is represented by a solid line and each indirect comparison by a dotted line. …

… In conclusion, combination IFN-R is the new first line treatment for chronic hepatitis C. Based
on the data from the currently available studies and the relative risks and response factor …

… IFN as a first-line therapy in chronic hepatitis D. Nucleoside analogues that inhibit hepatitis
B virus (HBV) are ineffective against HDV and combination therapy with lamivudine or …

… The use of adefovir as a first line agent for treatment naïve CHB patients is limited by its
modest antiviral suppressive effect and its potential renal toxicity. It has mainly been used in …

… Today, combination of peginterferon with ribavirin has become the standard treatment for
chronic hepatitis C. Both available peginterferon-α2 preparations in combination with ribavirin …

… We advise that patients should only receive PEG-IFN as first-line treatment if the baseline
probability of sustained virological response is greater than 30%, for only in this patient …

… approved as first-line therapy. In choosing which antiviral agent to use as the firstline therapy,
… antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum …

… first-line therapy and related chronic liver disease costs (including medication and laboratory
tests) from the Hospital Management … in chronic hepatitis B prognosis by levels of hepatitis …